New guidelines: Importance to reduce LDL-C in patients at risk.

31 August 2020 (12:50 - 13:00)

Organised by:

Video

Sign in to view the resources

About the speaker

Professor Lluis Masana

University Hospital Sant Joan de Reus, Reus (Spain)

4 More presentations in this session

Presentation thumbnail

Welcome and introduction.

Professor J. Chapman (Paris, FR) Professor L. Tokgozoglu (Ankara, TR)

Presentation thumbnail

The role of add-on therapies in the management of high and very high CV risk patients.

Professor P. Perrone-Filardi (Naples, IT)

Presentation thumbnail

Novel options for the combination of LDL-C lowering therapies.

Professor K. Ray (London, GB)

Presentation thumbnail

Live Q & A with chairmen & speakers.

Professor L. Tokgozoglu (Ankara, TR) Professor J. Chapman (Paris, FR)

Access the full session

Session thumbnail

Add on to take back control: Combining lipid lowering therapies for the management of high risk patients

The Event

ESC Congress 2020

31 August 2020 12:50 CET

You may be interested in

Webinar

Update of the 2019 ESC Guidelines on Management of Dyslipidaemia: new recommendations and their impact on clinical practice

25 November 2025

Congress Presentation

Attainment of guideline recommended cholesterol goals in cardiovascular prevention results from a preventive cardio-rheuma clinic in norway

25 April 2024

Congress Presentation

Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients

3 April 2025

Congress Presentation

Bridging guidelines to practice: why patients remain outside of LDL-C goals

1 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources